Kontigo Care AB (publ) (KONT.ST)
SEK 2.64
(-1.49%)
SEK 2.64
(-1.49%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 2.74 Million SEK | -90.28% |
| 2022 | 28.23 Million SEK | 16.89% |
| 2021 | 24.15 Million SEK | 20.74% |
| 2020 | 20 Million SEK | 15.07% |
| 2019 | 17.38 Million SEK | 32.26% |
| 2018 | 13.14 Million SEK | 115.12% |
| 2017 | 6.11 Million SEK | 494.45% |
| 2016 | 1.02 Million SEK | -88.25% |
| 2015 | 8.75 Million SEK | -19.22% |
| 2014 | 10.83 Million SEK | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 201 Thousand SEK | 138.73% |
| 2024 Q2 | 516 Thousand SEK | 156.72% |
| 2023 Q3 | 6.99 Million SEK | -30.54% |
| 2023 Q4 | -519 Thousand SEK | -107.42% |
| 2023 FY | 2.74 Million SEK | -90.28% |
| 2023 Q1 | 7.02 Million SEK | -0.21% |
| 2023 Q2 | 10.06 Million SEK | 43.26% |
| 2022 Q3 | 1.37 Million SEK | -81.2% |
| 2022 FY | 28.23 Million SEK | 16.89% |
| 2022 Q2 | 7.31 Million SEK | 8.95% |
| 2022 Q1 | 6.71 Million SEK | 4.54% |
| 2022 Q4 | 7.04 Million SEK | 412.15% |
| 2021 Q3 | 6.23 Million SEK | 5.93% |
| 2021 FY | 24.15 Million SEK | 20.74% |
| 2021 Q1 | 5.62 Million SEK | -1.34% |
| 2021 Q2 | 5.88 Million SEK | 4.72% |
| 2021 Q4 | 6.42 Million SEK | 3.0% |
| 2020 Q4 | 5.69 Million SEK | 9.39% |
| 2020 Q3 | 5.2 Million SEK | 7.67% |
| 2020 FY | 20 Million SEK | 15.07% |
| 2020 Q2 | 4.83 Million SEK | 13.26% |
| 2020 Q1 | 4.27 Million SEK | -3.18% |
| 2019 FY | 17.38 Million SEK | 32.26% |
| 2019 Q3 | 4.15 Million SEK | 2.85% |
| 2019 Q4 | 4.41 Million SEK | 6.25% |
| 2019 Q2 | 4.03 Million SEK | 12.61% |
| 2019 Q1 | 3.58 Million SEK | 18.34% |
| 2018 Q4 | 3.02 Million SEK | 13.3% |
| 2018 Q3 | 2.67 Million SEK | 3.77% |
| 2018 Q1 | 2.46 Million SEK | 345.36% |
| 2018 Q2 | 2.57 Million SEK | 4.33% |
| 2018 FY | 13.14 Million SEK | 115.12% |
| 2017 Q2 | 1.69 Million SEK | 12.76% |
| 2017 FY | 6.11 Million SEK | 494.45% |
| 2017 Q4 | 554.38 Thousand SEK | -76.47% |
| 2017 Q1 | 1.5 Million SEK | 286.82% |
| 2017 Q3 | 2.35 Million SEK | 38.83% |
| 2016 Q1 | -1.76 Million SEK | -227.43% |
| 2016 Q4 | 389.06 Thousand SEK | 146.99% |
| 2016 Q2 | -3.27 Million SEK | -85.06% |
| 2016 FY | 1.02 Million SEK | -88.25% |
| 2016 Q3 | -828 Thousand SEK | 74.68% |
| 2015 FY | 8.75 Million SEK | -19.22% |
| 2015 Q4 | 1.38 Million SEK | -60.74% |
| 2015 Q1 | 4.45 Million SEK | -24.38% |
| 2015 Q2 | 6.73 Million SEK | 51.21% |
| 2015 Q3 | 3.53 Million SEK | -47.58% |
| 2014 Q4 | 5.89 Million SEK | 163.29% |
| 2014 Q1 | 675.5 Thousand SEK | 0.0% |
| 2014 FY | 10.83 Million SEK | 0.0% |
| 2014 Q3 | 2.23 Million SEK | -17.17% |
| 2014 Q2 | 2.7 Million SEK | 300.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Aino Health AB (publ) | 3.79 Million SEK | 27.699% |
| Bonzun AB (publ) | -25.25 Million SEK | 110.873% |
| Medhelp Care Aktiebolag (publ) | 90.38 Million SEK | 96.962% |
| RaySearch Laboratories AB (publ) | 630.37 Million SEK | 99.564% |
| Surgical Science Sweden AB (publ) | 558.88 Million SEK | 99.509% |